These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3085632)

  • 1. Atrophie blanche. A disorder associated with defective release of tissue plasminogen activator.
    Pizzo SV; Murray JC; Gonias SL
    Arch Pathol Lab Med; 1986 Jun; 110(6):517-9. PubMed ID: 3085632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis.
    Jordan JM; Allen NB; Pizzo SV
    Am J Med; 1987 Mar; 82(3):397-400. PubMed ID: 3103439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of tissue plasminogen activator and its fast-acting inhibitor in defective fibrinolysis.
    Pizzo SV; Fuchs HE; Doman KA; Petruska DB; Berger H
    Arch Intern Med; 1986 Jan; 146(1):188-91. PubMed ID: 2935105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic abnormalities in two different cutaneous manifestations of venous disease.
    Margolis DJ; Kruithof EK; Barnard M; Howe K; Lazarus GS
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 1):204-8. PubMed ID: 8642083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Release pattern of the vascular plasminogen activator and its inhibitor in human postvenous occlusion plasma as assessed by a spectrophotometric solid-phase fibrin-tPA activity assay.
    Anglés-Cano E; Boutière B; Arnoux D; Masson C; Contant G; Benchimol P; Sampol J
    Thromb Haemost; 1987 Oct; 58(3):843-9. PubMed ID: 3124285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
    Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrinolytic activity and tissue plasminogen activator level in healthy individuals prior to and after a ten-minute venous stasis].
    Kubicka A; Libura M; Sacha T; Swadźba J; Undas A; Wandzilak M
    Pol Tyg Lek; 1993 Feb 1-8; 48(5-6):116-9. PubMed ID: 8361905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis in normal subjects--comparison between plasminogen activator inhibitor and other components of the fibrinolytic system.
    Nicoloso G; Hauert J; Kruithof EK; Van Melle G; Bachmann F
    Thromb Haemost; 1988 Apr; 59(2):299-303. PubMed ID: 3133812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
    Sultan Y; Harris A; Strauch G; Venot A; De Lauture D
    J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis.
    Awada H; Barlowatz-Meimon G; Dougados M; Maisonneuve P; Sultan Y; Amor B
    J Lab Clin Med; 1988 Feb; 111(2):229-36. PubMed ID: 3123585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL; Tse GH; Fox KA; Ludlam CA; Megson I; Newby DE
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):772-7. PubMed ID: 15681300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolytic activity during hemodialysis: a biocompatibility-related phenomenon.
    Martin-Malo A; Velasco F; Rojas R; Castillo D; Rodriguez M; Torres A; Aljama P
    Kidney Int Suppl; 1993 Jun; 41():S213-6. PubMed ID: 8320924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.